These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17548453)

  • 1. Autoimmune hemolytic anemia during interferon-beta-I b treatment for multiple sclerosis.
    Alanoglu G; Kilbas S; Arslan C; Senol A; Kutluhan S
    Mult Scler; 2007 Jun; 13(5):683-5. PubMed ID: 17548453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis.
    Bitsch A; Bahner D; Wachter C; Elitok E; Bogumil T; Dressel A; Polak T; Tumani H; Weber F; Poser S; Kitze B
    Acta Neurol Scand; 2004 Dec; 110(6):386-92. PubMed ID: 15527451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of injection site pain and injection site reactions in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a or 1b.
    Baum K; O'Leary C; Coret Ferrer F; Klímová E; Procházková L; Bugge J;
    Mult Scler; 2007 Nov; 13(9):1153-60. PubMed ID: 17967843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arthritis and bursitis in multiple sclerosis patients treated with interferon-beta.
    Strueby L; Nair B; Kirk A; Taylor-Gjevre RM
    Scand J Rheumatol; 2005; 34(6):485-8. PubMed ID: 16393774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Profile of efficacy and safety in the treatment of remittent-recurrent multiple sclerosis with interferon beta-1b].
    Río J; Marzo ME; Tintoré M; Borrás C; Montalbán X
    Neurologia; 1998 Nov; 13(9):422-6. PubMed ID: 9883016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis, interferon beta-1b and depression A prospective investigation.
    Feinstein A; O'Connor P; Feinstein K
    J Neurol; 2002 Jul; 249(7):815-20. PubMed ID: 12140662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evolution and adverse effects in patients with remittent-recurrent multiple sclerosis treated with interferon beta 1b. The influence of patient's weight and height].
    García-Moreno JM; Navarro G; Duque P; Gamero MA; Gata JM; Gálvez JL; Izquierdo G
    Neurologia; 1999 Apr; 14(4):154-8. PubMed ID: 10363489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon beta-1b retinopathy during a treatment for multiple sclerosis].
    Sommer S; Sablon JC; Zaoui M; Rozot P; Hosni A
    J Fr Ophtalmol; 2001 May; 24(5):509-12. PubMed ID: 11397988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe local skin reactions to interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection.
    Nakamura Y; Kawachi Y; Furuta J; Otsuka F
    Eur J Dermatol; 2008; 18(5):579-82. PubMed ID: 18693165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of interferon beta 1B on bone mineral density in multiple sclerosis patients.
    Varoglu AO; Varoglu E; Bayraktar R; Aygul R; Ulvi H; Yildirim K
    J Back Musculoskelet Rehabil; 2010; 23(1):25-9. PubMed ID: 20231786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotton wool spots associated with interferon beta-1 alpha therapy.
    Longmuir R; Lee AG; Rouleau J
    Semin Ophthalmol; 2007; 22(1):49-53. PubMed ID: 17366120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis.
    Uzawa A; Mori M; Hayakawa S; Masuda S; Kuwabara S
    Eur J Neurol; 2010 May; 17(5):672-6. PubMed ID: 20039942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon beta-1b exacerbates multiple sclerosis with severe optic nerve and spinal cord demyelination.
    Warabi Y; Matsumoto Y; Hayashi H
    J Neurol Sci; 2007 Jan; 252(1):57-61. PubMed ID: 17125797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune hepatitis and interferon beta-1a for multiple sclerosis.
    Duchini A
    Am J Gastroenterol; 2002 Mar; 97(3):767-8. PubMed ID: 11922585
    [No Abstract]   [Full Text] [Related]  

  • 17. Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient.
    Heinzerling L; Dummer R; Burg G; Schmid-Grendelmeier P
    Eur J Dermatol; 2002; 12(2):194-7. PubMed ID: 11872423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study.
    Flechter S; Vardi J; Finkelstein Y; Pollak L
    Isr Med Assoc J; 2007 Jun; 9(6):457-9. PubMed ID: 17642394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe liver dysfunction possibly caused by the combination of interferon beta-1b therapy and melilot (sweet clover) supplement.
    Tamura S; Warabi Y; Matsubara S
    J Clin Pharm Ther; 2012 Dec; 37(6):724-5. PubMed ID: 22642738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed drug eruption with interferon-beta-1b.
    Tai YJ; Tam M
    Australas J Dermatol; 2005 Aug; 46(3):154-7. PubMed ID: 16008645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.